IBS as it relates to FODMAP’s, Gluten, and Rifaximin

Sorry for the lack of video.  Had technical difficulties which will be resolved before our next broadcast.
Today we are discussing IBS as it relates to foods that may provoke an IBS patient’s symptoms as well as an antibiotic that is showing promise in helping some IBS patients.   FODMAP’s are foods that contain certain carbohydrate structures that can attract water into the gastrointestinal tract as well as feeding bacteria in the gut which can produce excessive gas.  In addition, today we will discuss the infamous gluten as it relates to gastrointestinal problems such as IBS as well as the wide spread manifestations of gluten, and lastly we will also discuss how Rifaximin, a locally acting antibiotic, can restore normalcy to the bowel health of an IBS patient.
Please enjoy, and send us your questions. Please forward us any questions here on our website or go to our Power Health Facebook page http://powerhealthreno.com/Facebook
1.Systematic review: dietary fibre and FODMAP-restricted diet in the management of constipation and irritable bowel syndrome.
Rao SS, Yu S, Fedewa A.
Aliment Pharmacol Ther. 2015 Apr 22. doi: 10.1111/apt.13167. [Epub ahead of print]
PMID: 25903636 [PubMed – as supplied by publisher]
Related citations
2.Clinical effectiveness and economic costs of group versus one-to-one education for short-chain fermentable carbohydrate restriction (low FODMAP diet) in the management of irritable bowel syndrome.
Whigham L, Joyce T, Harper G, Irving PM, Staudacher HM, Whelan K, Lomer MC.
J Hum Nutr Diet. 2015 Apr 14. doi: 10.1111/jhn.12318. [Epub ahead of print]
PMID: 25871564 [PubMed – as supplied by publisher]
Related citations
3.The Science, Evidence, and Practice of Dietary Interventions in Irritable Bowel Syndrome.
Lacy BE.
Clin Gastroenterol Hepatol. 2015 Mar 10. pii: S1542-3565(15)00248-7. doi: 10.1016/j.cgh.2015.02.043. [Epub ahead of print] Review.
PMID: 25769411 [PubMed – as supplied by publisher]
Related citations
4.Role of FODMAPs in Patients With Irritable Bowel Syndrome: A Review.
Mansueto P, Seidita A, D’Alcamo A, Carroccio A.
Nutr Clin Pract. 2015 Feb 18. pii: 0884533615569886. [Epub ahead of print] Review.
PMID: 25694210 [PubMed – as supplied by publisher]
Related citations
5.Food components and irritable bowel syndrome.
Gibson PR, Varney J, Malakar S, Muir JG.
Gastroenterology. 2015 May;148(6):1158-1174.e4. doi: 10.1053/j.gastro.2015.02.005. Epub 2015 Feb 11.
PMID: 25680668 [PubMed – in process]
Related citations
6.Nonceliac gluten sensitivity.
Fasano A, Sapone A, Zevallos V, Schuppan D.
Gastroenterology. 2015 May;148(6):1195-204. doi: 10.1053/j.gastro.2014.12.049. Epub 2015 Jan 9.
PMID: 25583468 [PubMed – in process]
Related citations
7.Ehealth: low FODMAP diet vs Lactobacillus rhamnosus GG in irritable bowel syndrome.
Pedersen N, Andersen NN, Végh Z, Jensen L, Ankersen DV, Felding M, Simonsen MH, Burisch J, Munkholm P.
World J Gastroenterol. 2014 Nov 21;20(43):16215-26. doi: 10.3748/wjg.v20.i43.16215.
PMID: 25473176 [PubMed – in process] Free PMC Article
Related citations
8.Low-FODMAP Diet for Irritable Bowel Syndrome: Is It Ready for Prime Time?
Khan MA, Nusrat S, Khan MI, Nawras A, Bielefeldt K.
Dig Dis Sci. 2014 Nov 20. [Epub ahead of print]
PMID: 25410635 [PubMed – as supplied by publisher]
Related citations
9.Abnormal accumulation of intestinal fluid following ingestion of an unabsorbable carbohydrate in patients with irritable bowel syndrome: an MRI study.
Undseth R, Berstad A, Kløw NE, Arnljot K, Moi KS, Valeur J.
Neurogastroenterol Motil. 2014 Dec;26(12):1686-93. doi: 10.1111/nmo.12449. Epub 2014 Oct 1.
PMID: 25271767 [PubMed – in process]
Related citations
10.The role of FODMAPs in irritable bowel syndrome.
Shepherd SJ, Halmos E, Glance S.
Curr Opin Clin Nutr Metab Care. 2014 Nov;17(6):605-9. doi: 10.1097/MCO.0000000000000116.
PMID: 25255126 [PubMed – in process]
Related citations
11.Confocal endomicroscopy shows food-associated changes in the intestinal mucosa of patients with irritable bowel syndrome.
Fritscher-Ravens A, Schuppan D, Ellrichmann M, Schoch S, Röcken C, Brasch J, Bethge J, Böttner M, Klose J, Milla PJ.
Gastroenterology. 2014 Nov;147(5):1012-20.e4. doi: 10.1053/j.gastro.2014.07.046. Epub 2014 Jul 30.
PMID: 25083606 [PubMed – indexed for MEDLINE]
Related citations
12.Interaction between ingested nutrients and gut endocrine cells in patients with irritable bowel syndrome (review).
El-Salhy M, Gilja OH, Gundersen D, Hatlebakk JG, Hausken T.
Int J Mol Med. 2014 Aug;34(2):363-71. doi: 10.3892/ijmm.2014.1811. Epub 2014 Jun 17. Review.
PMID: 24939595 [PubMed – indexed for MEDLINE] Free PMC Article
Related citations
13.Ehealth monitoring in irritable bowel syndrome patients treated with low fermentable oligo-, di-, mono-saccharides and polyols diet.
Pedersen N, Vegh Z, Burisch J, Jensen L, Ankersen DV, Felding M, Andersen NN, Munkholm P.
World J Gastroenterol. 2014 Jun 7;20(21):6680-4. doi: 10.3748/wjg.v20.i21.6680.
PMID: 24914395 [PubMed – indexed for MEDLINE] Free PMC Article
Related citations
14.[Malabsorption of fermentable oligo-, di-, or monosaccharides and polyols (FODMAP) as a common cause of unclear abdominal discomfort].
Goebel-Stengel M, Mönnikes H.
Dtsch Med Wochenschr. 2014 Jun;139(24):1310-4. doi: 10.1055/s-0034-1370108. Epub 2014 Jun 3. Review. German.
PMID: 24892470 [PubMed – indexed for MEDLINE]
Related citations
15.Fermentable oligosaccharides, disaccharides, monosaccharides and polyols: role in irritable bowel syndrome.
Tuck CJ, Muir JG, Barrett JS, Gibson PR.
Expert Rev Gastroenterol Hepatol. 2014 Sep;8(7):819-34. doi: 10.1586/17474124.2014.917956. Epub 2014 May 15.
PMID: 24830318 [PubMed – in process]
Related citations
16.[The low FODMAP diet as a therapy for irritable bowel syndrome].
van der Waaij LA, Stevens J.
Ned Tijdschr Geneeskd. 2014;158:A7407. Review. Dutch.
PMID: 24823855 [PubMed – indexed for MEDLINE]
Related citations
17.[Importance of diet in irritable bowel syndrome].
Mearin F, Peña E, Balboa A.
Gastroenterol Hepatol. 2014 May;37(5):302-10. doi: 10.1016/j.gastrohep.2013.12.010. Epub 2014 Feb 28. Spanish.
PMID: 24582764 [PubMed – in process]
Related citations
18.Mechanisms and efficacy of dietary FODMAP restriction in IBS.
Staudacher HM, Irving PM, Lomer MC, Whelan K.
Nat Rev Gastroenterol Hepatol. 2014 Apr;11(4):256-66. doi: 10.1038/nrgastro.2013.259. Epub 2014 Jan 21. Review.
PMID: 24445613 [PubMed – indexed for MEDLINE]
Related citations
19.Functional bowel symptoms and diet.
Gibson PR, Barrett JS, Muir JG.
Intern Med J. 2013 Oct;43(10):1067-74. doi: 10.1111/imj.12266. Review.
PMID: 24134168 [PubMed – indexed for MEDLINE]
Related citations
20.Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome.
Ong DK, Mitchell SB, Barrett JS, Shepherd SJ, Irving PM, Biesiekierski JR, Smith S, Gibson PR, Muir JG.
J Gastroenterol Hepatol. 2010 Aug;25(8):1366-73. doi: 10.1111/j.1440-1746.2010.06370.x.
PMID: 20659225 [PubMed – indexed for MEDLINE]
Related citations
21.[Pharmacotherapy for irritable bowel syndrome in the context of evidence-based medicine].
[No authors listed]
Ter Arkh. 2015;87(2):4-10. Russian.
PMID: 25864340 [PubMed – in process]
Related citations
22.Rifaximin for the treatment of diarrhoea-predominant irritable bowel syndrome.
Laterza L, Ianiro G, Scoleri I, Landi R, Bruno G, Scaldaferri F, Gaetani E, Campanale M, Gasbarrini A.
Expert Opin Pharmacother. 2015 Mar;16(4):607-15. doi: 10.1517/14656566.2015.1007951. Epub 2015 Feb 1.
PMID: 25641072 [PubMed – in process]
Related citations
23.Small intestinal bacterial overgrowth is associated to symptoms in irritable bowel syndrome. Evidence from a multicentre study in Romania.
Moraru IG, Moraru AG, Andrei M, Iordache T, Drug V, Diculescu M, Portincasa P, Dumitrascu DL.
Rom J Intern Med. 2014;52(3):143-50.
PMID: 25509557 [PubMed – indexed for MEDLINE]
Related citations
24.Irritable bowel syndrome: a concise review of current treatment concepts.
Wall GC, Bryant GA, Bottenberg MM, Maki ED, Miesner AR.
World J Gastroenterol. 2014 Jul 21;20(27):8796-806. doi: 10.3748/wjg.v20.i27.8796. Review.
PMID: 25083054 [PubMed – indexed for MEDLINE] Free PMC Article
Related citations
25.Medication management of irritable bowel syndrome.
Trinkley KE, Nahata MC.
Digestion. 2014;89(4):253-67. doi: 10.1159/000362405. Epub 2014 Jul 2.
PMID: 24992947 [PubMed – in process] Free Article
Related citations
26.Herbal therapy is equivalent to rifaximin for the treatment of small intestinal bacterial overgrowth.
Chedid V, Dhalla S, Clarke JO, Roland BC, Dunbar KB, Koh J, Justino E, Tomakin E, Mullin GE.
Glob Adv Health Med. 2014 May;3(3):16-24. doi: 10.7453/gahmj.2014.019.
PMID: 24891990 [PubMed]
Related citations
27.Microbiota, gastrointestinal infections, low-grade inflammation, and antibiotic therapy in irritable bowel syndrome: an evidence-based review.
Schmulson M, Bielsa MV, Carmona-Sánchez R, Hernández A, López-Colombo A, López Vidal Y, Peláez-Luna M, Remes-Troche JM, Tamayo JL, Valdovinos MA.
Rev Gastroenterol Mex. 2014 Apr-Jun;79(2):96-134. doi: 10.1016/j.rgmx.2014.01.004. Epub 2014 May 23. English, Spanish.
PMID: 24857420 [PubMed – in process] Free Article
Related citations
28.Treatment of abdominal pain in irritable bowel syndrome.
Vanuytsel T, Tack JF, Boeckxstaens GE.
J Gastroenterol. 2014 Aug;49(8):1193-205. doi: 10.1007/s00535-014-0966-7. Epub 2014 May 21. Review.
PMID: 24845149 [PubMed – indexed for MEDLINE]
Related citations
29.The safety of novel drugs used to treat irritable bowel syndrome.
Mozaffari S, Nikfar S, Abdollahi M.
Expert Opin Drug Saf. 2014 May;13(5):625-38. doi: 10.1517/14740338.2014.902932. Epub 2014 Mar 26. Review.
PMID: 24669839 [PubMed – indexed for MEDLINE]
Related citations
30.A study of the methodological and clinical validity of the combined lactulose hydrogen breath test with scintigraphic oro-cecal transit test for diagnosing small intestinal bacterial overgrowth in IBS patients.
Zhao J, Zheng X, Chu H, Zhao J, Cong Y, Fried M, Fox M, Dai N.
Neurogastroenterol Motil. 2014 Jun;26(6):794-802. doi: 10.1111/nmo.12331. Epub 2014 Mar 18.
PMID: 24641100 [PubMed – indexed for MEDLINE]
Related citations
31.[Role of rifaximin in correction of IBS-like symptoms in patients with inflammatory bowel disease].
Belous SS, Khalif IL, Golovenko OV.
Eksp Klin Gastroenterol. 2013;(3):63-8. Review. Russian.
PMID: 24294774 [PubMed – indexed for MEDLINE]
Related citations
32.Comparison of the antibacterial activity of essential oils and extracts of medicinal and culinary herbs to investigate potential new treatments for irritable bowel syndrome.
Thompson A, Meah D, Ahmed N, Conniff-Jenkins R, Chileshe E, Phillips CO, Claypole TC, Forman DW, Row PE.
BMC Complement Altern Med. 2013 Nov 28;13:338. doi: 10.1186/1472-6882-13-338.
PMID: 24283351 [PubMed – indexed for MEDLINE] Free PMC Article
Related citations
33.Rifaximin in irritable bowel syndrome: rationale, evidence and clinical use.
Saadi M, McCallum RW.
Ther Adv Chronic Dis. 2013 Mar;4(2):71-5. doi: 10.1177/2040622312472008.
PMID: 23556126 [PubMed] Free PMC Article
Related citations
34.Intestinal permeability defects: is it time to treat?
Odenwald MA, Turner JR.
Clin Gastroenterol Hepatol. 2013 Sep;11(9):1075-83. doi: 10.1016/j.cgh.2013.07.001. Epub 2013 Jul 12. Review.
PMID: 23851019 [PubMed – indexed for MEDLINE] Free PMC Article
Related citations
35.Leaky gut in patients with diarrhea-predominant irritable bowel syndrome and inactive ulcerative colitis.
Gecse K, Róka R, Séra T, Rosztóczy A, Annaházi A, Izbéki F, Nagy F, Molnár T, Szepes Z, Pávics L, Bueno L, Wittmann T.
Digestion. 2012;85(1):40-6. doi: 10.1159/000333083. Epub 2011 Dec 14.
PMID: 22179430 [PubMed – indexed for MEDLINE]
Related citations

Leave a Comment

Your email address will not be published. Required fields are marked *